Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Identification of Novel Anthracycline Resistance Genes and Their InhibitorsOnat Kadioglu, Mohamed Elbadawi, Edmond Fleischer, et al.
Biochemical Pharmacology|October 25, 2017
Lawsone derivatives target the Wnt/β-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cellsSami Hamdoun, Edmond Fleischer, Anette Klinger, et al.
Molecules (Basel, Switzerland)|July 19, 2020
Chemometric and Transcriptomic Profiling, Microtubule Disruption and Cell Death Induction by Secalonic Acid in Tumor CellsNadire Özenver, Mona Dawood, Edmond Fleischer, et al.
Investigational New Drugs|September 26, 2020
Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myelomaNadire Özenver, Sara Abdelfatah, Anette Klinger, et al.
Archives of Toxicology|May 22, 2021
Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validationOnat Kadioglu, Sabine M Klauck, Edmond Fleischer, et al.
Chemico-Biological Interactions|December 1, 2020
AMG900 as novel inhibitor of the translationally controlled tumor proteinNicolas Fischer, Ean-Jeong Seo, Anette Klinger, et al.
Pharmacological Research|July 14, 2020
Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344Mona Dawood, Edmond Fleischer, Anette Klinger, et al.
Investigational New Drugs|March 17, 2019
Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compoundsSara Abdelfatah, Edmond Fleischer, Anette Klinger, et al.
Investigational New Drugs|January 25, 2021
A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapyNicolas Fischer, Ean-Jeong Seo, Sara Abdelfatah, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 28, 2022
Transcriptomics, molecular docking, and cross-resistance profiling of nobiletin in cancer cells and synergistic interaction with doxorubicin upon SOX5 transfectionAveen N Adham, Sara Abdelfatah, Alaadin Naqishbandi, et al.
Pageof 3